Anterior Abdominal Wall Ecchymosis in COVID-19 Patient Following Enoxaparin Use

IF 0.3 Q4 CRITICAL CARE MEDICINE
Neeraj Kumar, Abhyuday Kumar, Amarjeet Kumar, Ammu Rose Shaju, Kunal Singh
{"title":"Anterior Abdominal Wall Ecchymosis in COVID-19 Patient Following Enoxaparin Use","authors":"Neeraj Kumar, Abhyuday Kumar, Amarjeet Kumar, Ammu Rose Shaju, Kunal Singh","doi":"10.1097/ej9.0000000000000041","DOIUrl":null,"url":null,"abstract":"Background: The role of anticoagulation in preventing and treating thromboembolic events due to presence of micro thrombosis that may affect various end-organs especially in coronavirus disease-19 (COVID-19). Patients receiving some form of anticoagulation therapy are predisposed to more risks of bleeding complications. These bleeding may range from minor to major, or even life-threatening events. Purpose: Low molecular weight heparin (LMWH) is one of the commonly used treatment modalities in COVID-19 and its complications are thrombocytopenia, anemia, bruises, and the rare ones are ecchymosis and/ or hematoma. Case presentation: A 75-year-old male COVID-19 patient weighing 85 kg was admitted to our intensive care unit (ICU) with shortness of breath, dry cough, and myalgia. On the 10th day, he develops ecchymotic patches over the anterior abdominal wall following administration of subcutaneous enoxaparin. This case describes the importance ofindividualizing the dose ofLMWH based on several risk factors.","PeriodicalId":31233,"journal":{"name":"Egyptian Journal of Critical Care Medicine","volume":null,"pages":null},"PeriodicalIF":0.3000,"publicationDate":"2022-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Egyptian Journal of Critical Care Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/ej9.0000000000000041","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The role of anticoagulation in preventing and treating thromboembolic events due to presence of micro thrombosis that may affect various end-organs especially in coronavirus disease-19 (COVID-19). Patients receiving some form of anticoagulation therapy are predisposed to more risks of bleeding complications. These bleeding may range from minor to major, or even life-threatening events. Purpose: Low molecular weight heparin (LMWH) is one of the commonly used treatment modalities in COVID-19 and its complications are thrombocytopenia, anemia, bruises, and the rare ones are ecchymosis and/ or hematoma. Case presentation: A 75-year-old male COVID-19 patient weighing 85 kg was admitted to our intensive care unit (ICU) with shortness of breath, dry cough, and myalgia. On the 10th day, he develops ecchymotic patches over the anterior abdominal wall following administration of subcutaneous enoxaparin. This case describes the importance ofindividualizing the dose ofLMWH based on several risk factors.
新冠肺炎患者应用依诺肝素后腹壁前淤血
背景:抗凝在预防和治疗因存在微血栓形成而导致的血栓栓塞事件中的作用,微血栓形成可能影响各种终末期器官,尤其是在冠状病毒疾病-19(新冠肺炎)中。接受某种形式的抗凝治疗的患者更容易发生出血并发症。这些出血可能从轻微到严重,甚至危及生命。目的:低分子肝素(LMWH)是新冠肺炎常用的治疗方法之一,其并发症包括血小板减少、贫血、瘀伤,罕见的有瘀斑和/或血肿。病例介绍:一名75岁男性新冠肺炎患者因呼吸急促、干咳和肌痛,体重85公斤,入住重症监护室(ICU)。第10天,皮下注射依诺肝素后,他在前腹壁上出现瘀斑。这个案例描述了基于几个风险因素对LMWH剂量进行个体化的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
5
审稿时长
42 weeks
期刊介绍: The Egyptian Journal of Critical Care Medicine is the official Journal of the Egyptian College of Critical Care Physicians, the most authoritative organization of Egyptian physicians involved in the multi-professional field of critical care medicine. The journal is intended to provide a peer-reviewed source for multidisciplinary coverage of general acute and intensive care medicine and its various subcategories including cardiac, pulmonary, neuro, renal as well as post-operative care. The journal is proud to have an international multi-professional editorial board in the broad field of critical care that will assist in publishing promising research and breakthrough reports that lead to better patients care in life threatening conditions, and bring the reader a quick access to the latest diagnostic and therapeutic approaches in monitoring and management of critically ill patients.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信